Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Allogeneic MSC Therapy in Renal Transplant Recipients
NCT02387151Phase 1Completed
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2015
- Primary completion
- Nov 2018
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Provacel in Kidney Transplant Rejection, sponsored by Leiden University Medical Center. Primary endpoint: Biopsy Proven Acute Rejection / Graft Loss at 12 months. Started Mar 2015; status: completed.
02
Drugs
Provacel
03
Conditions
Kidney Transplant Rejection
Beyond the preview
Go deeper on NCT02387151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387151.